abstract |
The invention relates to compounds selected from among the group comprising general formulas (1), (2), (3), and/or (4) and/or the enantiomers, diastereomers, and derivatives thereof, and the pharmaceutically acceptable salts thereof for producing a medicament used for therapeutically and/or preventively treating diseases and pathological conditions linked to regulation of the insulin and/or insulin-like growth factor (IGF) signaling pathway and/or for chemically inducing longevity. |